Under the terms of the agreement, Rona will receive upfront and near-term milestone payments of up to $100M and is eligible ...

Exclusive agreement grants Visara worldwide rights outside Greater China to develop HT006.2.2 for neurotrophic keratitis, ...

In preclinical studies, ISM9546 exhibited sub-nanomolar VAV1 degradation potency across multiple cell-based assays. Oral ...

South Korea’s GCCL and LabConnect Partner to Strengthen Global Clinical Trial Operations Across APAC and North America ...

Waters Corporation announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context ...

Shanghai Ark Biopharmaceutical Secures US FDA IND Clearance for Phase II Trial of Long-Acting Influenza Prevention Drug ...

BioAgilytix company, announced the opening of a new Australian laboratory in Sydney, expanding its national footprint to four ...

Suvoda, a global clinical trial technology company, announced that Sofia, its AI assistant on the Suvoda Platform, is ready ...

CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...

LOTTE Biologics, a contract development and manufacturing (CDMO) organization, and Alvotech, a global biotechnology company ...

Five of the twelve Presidential Symposium late-breakers in Madrid trace back to molecules discovered in China. Here is what ...

RESTORE-3 study demonstrates a 60.4% proptosis response rate versus 23.5% with placebo at Week 24, highlighting the potential ...